Palisade Bio, Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Karl Johe. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Karl Johe has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CUR / Neuralstem, Inc. Chief Scientific Officer, Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Karl Johe. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases PALI / Palisade Bio, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in PALI / Palisade Bio, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PALI / Palisade Bio, Inc. Insider Trades
Insider Sales PALI / Palisade Bio, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in PALI / Palisade Bio, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PALI / Palisade Bio, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Karl Johe as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2015-11-20 2015-11-19 4 CUR Neuralstem, Inc.
Restricted Stock Unit
M - Exercise -143,247 0 -100.00
2015-11-20 2015-11-19 4 CUR Neuralstem, Inc.
Common Stock
F - Taxes -39,178 930,373 -4.04 1.14 -44,663 1,060,625
2015-11-20 2015-11-19 4 CUR Neuralstem, Inc.
Common Stock
M - Exercise 143,247 969,551 17.34
2015-11-16 2015-11-16 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 826,304 -2.94 1.09 -27,250 900,671
2015-11-09 2015-11-09 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 851,304 -2.85 1.18 -29,500 1,004,539
2015-11-03 2015-11-02 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 876,304 -2.77 1.17 -29,355 1,028,956
2015-10-27 2015-10-26 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 901,304 -2.70 1.13 -28,190 1,016,310
2015-10-19 2015-10-19 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 926,304 -2.63 1.23 -30,690 1,137,131
2015-10-13 2015-10-12 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 951,304 -2.56 1.31 -32,725 1,245,257
2015-10-05 2015-10-05 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 976,304 -2.50 1.26 -31,460 1,228,581
2015-09-28 2015-09-28 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 1,001,304 -2.44 1.64 -41,000 1,642,139
2015-09-21 2015-09-21 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -25,000 1,026,304 -2.38 1.52 -38,078 1,563,164
2015-08-18 2015-08-13 4 CUR Neuralstem, Inc.
Common Stock
J - Other -16,627 1,051,304 -1.56
2015-07-24 2015-07-22 4 CUR Neuralstem, Inc.
Common Stock purchase option
M - Exercise -1,200,000 0 -100.00
2015-07-24 2015-07-22 4 CUR Neuralstem, Inc.
Common Stock
F - Taxes -621,016 1,067,931 -36.77 1.64 -1,018,466 1,751,407
2015-07-24 2015-07-22 4 CUR Neuralstem, Inc.
Common Stock
M - Exercise 1,200,000 1,688,947 245.43 0.50 600,000 844,474
2015-04-20 2015-04-17 4 CUR Neuralstem, Inc.
Common Stock
G - Gift -6,800 488,947 -1.37
2015-04-02 2015-02-20 4 CUR Neuralstem, Inc.
Common Stock Purchase Option
A - Award 315,126 315,126
2014-09-05 2014-04-03 4/A CUR Neuralstem, Inc.
Common Stock
G - Gift 17,500 495,747 3.66
2014-09-03 2014-09-02 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 495,747 -1.20 4.09 -24,540 2,027,605
2014-08-04 2014-08-01 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 484,247 -1.22 2.78 -16,680 1,346,207
2014-07-01 2014-07-01 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 490,247 -1.21 4.17 -25,020 2,044,330
2014-06-02 2014-06-02 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 496,247 -1.19 4.25 -25,500 2,109,050
2014-05-05 2014-05-01 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 502,247 -1.18 3.54 -21,255 1,779,210
2014-04-04 2014-04-03 4 CUR Neuralstem, Inc.
Common Stock
G - Gift -17,500 508,247 -3.33
2014-04-02 2014-04-01 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 525,747 -1.13 4.11 -24,638 2,158,875
2014-03-21 2014-03-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -6,000 531,747 -1.12 4.04 -24,249 2,149,056
2014-02-04 2014-01-28 4 CUR Neuralstem, Inc.
Common Stock Purchase Option
A - Award 200,324 200,324
2013-12-05 2013-12-05 4 CUR Neuralstem, Inc.
Common Stock
G - Gift -4,000 680,994 -0.58
2013-11-07 2013-10-21 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -10,000 684,994 -1.44 2.35 -23,458 1,606,859
2013-10-21 2013-10-18 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -10,000 694,994 -1.42 2.44 -24,446 1,698,982
2013-09-23 2013-09-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -10,000 704,994 -1.40 2.62 -26,241 1,849,975
2013-09-19 2013-09-19 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -10,000 714,994 -1.38 2.61 -26,094 1,865,705
2013-08-21 2013-08-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -20,000 724,994 -2.68 1.55 -30,986 1,123,233
2013-07-22 2013-07-22 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 744,994 -1.69 1.62 -20,780 1,209,423
2013-06-21 2013-06-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 757,794 -1.66 1.40 -17,856 1,057,123
2013-05-21 2013-05-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 770,594 -1.63 1.51 -19,301 1,161,979
2013-04-23 2013-04-22 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 783,394 -1.61 1.13 -14,520 888,682
2013-04-10 2013-03-28 4 CUR Neuralstem, Inc.
Common Stock Purchase Option
A - Award 592,219 592,219
2013-03-22 2013-03-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 796,194 -1.58 1.14 -14,546 904,795
2013-02-21 2013-02-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 808,994 -1.56 1.18 -15,104 954,613
2013-01-30 2012-04-11 5 CUR Neuralstem, Inc.
Common Stock Purchase Option
A - Award 738,479 738,479
2013-01-23 2013-01-22 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 821,794 -1.53 1.27 -16,256 1,043,678
2012-12-26 2012-12-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 834,594 -1.51 1.16 -14,822 966,460
2012-11-27 2012-11-20 4 CUR Neuralstem, Inc.
Common Stock
S - Sale X -12,800 847,394 -1.49 1.00 -12,800 847,394
2012-07-27 2012-07-25 4 CUR Neuralstem, Inc.
Common Stock Purchase Option
A - Award 5,000,000 5,000,000
2012-06-20 2012-06-18 4 CUR Neuralstem, Inc.
Common Stock
J - Other -256,790 860,194 -22.99
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)